Page last updated: 2024-10-20

pyridoxal and Thalassemia

pyridoxal has been researched along with Thalassemia in 2 studies

Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brittenham, GM1
Anderson, BB1
Mollin, DL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Chelation Therapy of Iron Overload With Oral Pyridoxal Isonicotinoyl Hydrazone[NCT00000588]Phase 2120 participants (Actual)Interventional1989-06-05Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for pyridoxal and Thalassemia

ArticleYear
Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.
    Annals of the New York Academy of Sciences, 1990, Volume: 612

    Topics: Administration, Oral; Animals; Drug Evaluation; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal;

1990

Trials

1 trial available for pyridoxal and Thalassemia

ArticleYear
Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.
    Annals of the New York Academy of Sciences, 1990, Volume: 612

    Topics: Administration, Oral; Animals; Drug Evaluation; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal;

1990

Other Studies

1 other study available for pyridoxal and Thalassemia

ArticleYear
Red-cell metabolism of pyridoxine in sideroblastic anaemias and related anaemias.
    British journal of haematology, 1972, Volume: 23

    Topics: Adenosine Triphosphate; Adult; Aged; Anemia, Hypochromic; Anemia, Sideroblastic; Biological Assay; E

1972